{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:15:09Z","timestamp":1767140109569,"version":"build-2238731810"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00520-024-09082-1","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T16:01:56Z","timestamp":1734105716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The contribution of nonmedical opioid use to healthcare encounters for opioid overdose and use disorders among long-term users with metastatic cancer"],"prefix":"10.1007","volume":"33","author":[{"given":"Hannah","family":"Harsanyi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winson","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Cuthbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"9082_CR1","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/JCO.22.02198","volume":"41","author":"JA Paice","year":"2023","unstructured":"Paice JA, Bohlke K, Barton D et al (2023) Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. J Clin Oncol 41:914\u2013930. https:\/\/doi.org\/10.1200\/JCO.22.02198","journal-title":"J Clin Oncol"},{"key":"9082_CR2","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jpainsymman.2015.12.340","volume":"51","author":"MHJ Van Den Beuken-van Everdingen","year":"2016","unstructured":"Van Den Beuken-van Everdingen MHJ, Hochstenbach LMJ, Joosten EAJ et al (2016) Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage 51:1070-1090.e9. https:\/\/doi.org\/10.1016\/j.jpainsymman.2015.12.340","journal-title":"J Pain Symptom Manage"},{"key":"9082_CR3","doi-asserted-by":"publisher","first-page":"pkae012","DOI":"10.1093\/jncics\/pkae012","volume":"8","author":"SC Mudumbai","year":"2024","unstructured":"Mudumbai SC, He H, Chen J-Q et al (2024) Opioid use in cancer patients compared with noncancer pain patients in a veteran population. JNCI Cancer Spectr 8:pkae012. https:\/\/doi.org\/10.1093\/jncics\/pkae012","journal-title":"JNCI Cancer Spectr"},{"issue":"1","key":"9082_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/FTD.0000000000000817","volume":"43","author":"PJ Jannetto","year":"2020","unstructured":"Jannetto PJ (2020) The North American Opioid Epidemic. Ther Drug Monit 43(1):1\u20135","journal-title":"Ther Drug Monit"},{"key":"9082_CR5","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jamaoncol.2020.0799","volume":"6","author":"F Chino","year":"2020","unstructured":"Chino F, Kamal A, Chino J (2020) Incidence of Opioid-Associated Deaths in Cancer Survivors in the United States, 2006\u20132016: A Population Study of the Opioid Epidemic. JAMA Oncol 6:1100. https:\/\/doi.org\/10.1001\/jamaoncol.2020.0799","journal-title":"JAMA Oncol"},{"key":"9082_CR6","doi-asserted-by":"publisher","first-page":"e1030","DOI":"10.1200\/OP.20.01041","volume":"17","author":"Y Schenker","year":"2021","unstructured":"Schenker Y, Hamm M, Bulls HW et al (2021) This Is a Different Patient Population: Opioid Prescribing Challenges for Patients With Cancer-Related Pain. JCO Oncol Pract 17:e1030\u2013e1037. https:\/\/doi.org\/10.1200\/OP.20.01041","journal-title":"JCO Oncol Pract"},{"key":"9082_CR7","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1158\/1055-9965.EPI-20-0628","volume":"29","author":"M Falcone","year":"2020","unstructured":"Falcone M, Luo C, Chen Y et al (2020) Risk of Persistent Opioid Use following Major Surgery in Matched Samples of Patients with and without Cancer. Cancer Epidemiol Biomarkers Prev 29:2126\u20132133. https:\/\/doi.org\/10.1158\/1055-9965.EPI-20-0628","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9082_CR8","doi-asserted-by":"publisher","first-page":"e752","DOI":"10.1097\/SLA.0000000000005109","volume":"277","author":"N Lin","year":"2023","unstructured":"Lin N, Dabas E, Quan ML et al (2023) Outcomes and Healthcare Utilization Among New Persistent Opioid Users and Nonopioid Users After Curative-intent Surgery for Cancer. Ann Surg 277:e752\u2013e758. https:\/\/doi.org\/10.1097\/SLA.0000000000005109","journal-title":"Ann Surg"},{"key":"9082_CR9","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1200\/JCO.2017.74.1363","volume":"35","author":"JS-J Lee","year":"2017","unstructured":"Lee JS-J, Hu HM, Edelman AL et al (2017) New Persistent Opioid Use Among Patients With Cancer After Curative-Intent Surgery. J Clin Oncol 35:4042\u20134049. https:\/\/doi.org\/10.1200\/JCO.2017.74.1363","journal-title":"J Clin Oncol"},{"key":"9082_CR10","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3390\/jcm11061594","volume":"11","author":"C Preux","year":"2022","unstructured":"Preux C, Bertin M, Tarot A et al (2022) Prevalence of Opioid Use Disorder among Patients with Cancer-Related Pain: A Systematic Review. J Clin Med 11:1594. https:\/\/doi.org\/10.3390\/jcm11061594","journal-title":"J Clin Med"},{"key":"9082_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1747-597X-8-39","volume":"8","author":"P Voon","year":"2013","unstructured":"Voon P, Kerr T (2013) \u201cNonmedical\u201d prescription opioid use in North America: a call for priority action. Subst Abuse Treat Prev Policy 8:39. https:\/\/doi.org\/10.1186\/1747-597X-8-39","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"9082_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1634\/theoncologist.2019-0540","volume":"25","author":"E Ulker","year":"2020","unstructured":"Ulker E, Del Fabbro E (2020) Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain. Oncologist 25:189\u2013196. https:\/\/doi.org\/10.1634\/theoncologist.2019-0540","journal-title":"Oncologist"},{"key":"9082_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/JCO.21.02086","volume":"40","author":"TN Townsend","year":"2022","unstructured":"Townsend TN, Bohnert ASB, Merlin JS (2022) Opioid Prescribing to Patients With Advanced Cancer: Unanswered Questions. J Clin Oncol 40:311\u2013312. https:\/\/doi.org\/10.1200\/JCO.21.02086","journal-title":"J Clin Oncol"},{"key":"9082_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1634\/theoncologist.2015-0012","volume":"20","author":"JH Kwon","year":"2015","unstructured":"Kwon JH, Tanco K, Park JC et al (2015) Frequency, Predictors, and Medical Record Documentation of Chemical Coping Among Advanced Cancer Patients. Oncologist 20:692\u2013697. https:\/\/doi.org\/10.1634\/theoncologist.2015-0012","journal-title":"Oncologist"},{"key":"9082_CR15","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1016\/j.pain.2014.09.034","volume":"155","author":"ER Vanderlip","year":"2014","unstructured":"Vanderlip ER, Sullivan MD, Edlund MJ et al (2014) National study of discontinuation of long-term opioid therapy among veterans. PAIN\u00ae 155:2673\u20132679. https:\/\/doi.org\/10.1016\/j.pain.2014.09.034","journal-title":"PAIN\u00ae"},{"key":"9082_CR16","doi-asserted-by":"publisher","first-page":"E547","DOI":"10.1503\/cmaj.231419","volume":"196","author":"J Lau","year":"2024","unstructured":"Lau J, Scott MM, Everett K et al (2024) Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada. Can Med Assoc J 196:E547\u2013E557. https:\/\/doi.org\/10.1503\/cmaj.231419","journal-title":"Can Med Assoc J"},{"key":"9082_CR17","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jpain.2015.12.006","volume":"17","author":"P Dilokthornsakul","year":"2016","unstructured":"Dilokthornsakul P, Moore G, Campbell JD et al (2016) Risk Factors of Prescription Opioid Overdose Among Colorado Medicaid Beneficiaries. J Pain 17:436\u2013443. https:\/\/doi.org\/10.1016\/j.jpain.2015.12.006","journal-title":"J Pain"},{"key":"9082_CR18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1471-2458-11-94","volume":"11","author":"Y-H Lee","year":"2011","unstructured":"Lee Y-H, Shin M-H, Kweon S-S et al (2011) Cumulative smoking exposure, duration of smoking cessation, and peripheral arterial disease in middle-aged and older Korean men. BMC Public Health 11:94. https:\/\/doi.org\/10.1186\/1471-2458-11-94","journal-title":"BMC Public Health"},{"key":"9082_CR19","doi-asserted-by":"publisher","unstructured":"Del Fabbro E, Carmichael A-N, Morgan L (2016) Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review. Subst Abuse Rehabil 71. https:\/\/doi.org\/10.2147\/SAR.S85409","DOI":"10.2147\/SAR.S85409"},{"key":"9082_CR20","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/pme.12100","volume":"14","author":"D Koyyalagunta","year":"2013","unstructured":"Koyyalagunta D, Bruera E, Aigner C et al (2013) Risk Stratification of Opioid Misuse among Patients with Cancer Pain Using the SOAPP-SF. Pain Med 14:667\u2013675. https:\/\/doi.org\/10.1111\/pme.12100","journal-title":"Pain Med"},{"key":"9082_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","volume":"6","author":"LR Webster","year":"2005","unstructured":"Webster LR, Webster RM (2005) Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool. Pain Med 6:432\u2013442. https:\/\/doi.org\/10.1111\/j.1526-4637.2005.00072.x","journal-title":"Pain Med"},{"key":"9082_CR22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1177\/02692163211015567","volume":"35","author":"J Lau","year":"2021","unstructured":"Lau J, Mazzotta P, Fazelzad R et al (2021) Assessment tools for problematic opioid use in palliative care: A scoping review. Palliat Med 35:1295\u20131322. https:\/\/doi.org\/10.1177\/02692163211015567","journal-title":"Palliat Med"},{"key":"9082_CR23","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/j.jpainsymman.2022.12.014","volume":"65","author":"D Afezolli","year":"2023","unstructured":"Afezolli D, Flemig D, Easton E et al (2023) Standard Naloxone Prescribing for Palliative Care Cancer Patients on Opioid Therapy: A Single-Site Quality Improvement Pilot to Assess Attitudes and Access. J Pain Symptom Manag 65:e309\u2013e314. https:\/\/doi.org\/10.1016\/j.jpainsymman.2022.12.014","journal-title":"J Pain Symptom Manag"},{"key":"9082_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.7326\/M15-2771","volume":"165","author":"PO Coffin","year":"2016","unstructured":"Coffin PO, Behar E, Rowe C et al (2016) Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Ann Intern Med 165:245\u2013252. https:\/\/doi.org\/10.7326\/M15-2771","journal-title":"Ann Intern Med"},{"key":"9082_CR25","doi-asserted-by":"publisher","first-page":"e196215","DOI":"10.1001\/jamanetworkopen.2019.6215","volume":"2","author":"M Sohn","year":"2019","unstructured":"Sohn M, Talbert JC, Huang Z et al (2019) Association of Naloxone Coprescription Laws With Naloxone Prescription Dispensing in the United States. JAMA Netw Open 2:e196215. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.6215","journal-title":"JAMA Netw Open"},{"key":"9082_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1213\/ANE.0000000000006029","volume":"135","author":"HT Benzon","year":"2022","unstructured":"Benzon HT, Sun EC, Chou R (2022) The Opioid Crisis, Centers for Disease Control Opioid Guideline, and Naloxone Coprescription for Patients at Risk for Opioid Overdose. Anesth Analg 135:21\u201325. https:\/\/doi.org\/10.1213\/ANE.0000000000006029","journal-title":"Anesth Analg"},{"key":"9082_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s11864-022-00954-4","volume":"23","author":"N Bates","year":"2022","unstructured":"Bates N, Bello JK, Osazuwa-Peters N et al (2022) Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer. Curr Treat Options Oncol 23:348\u2013358. https:\/\/doi.org\/10.1007\/s11864-022-00954-4","journal-title":"Curr Treat Options Oncol"},{"key":"9082_CR28","doi-asserted-by":"publisher","unstructured":"(2020) The Prescription Opioids and Depression Pathways Cohort Study. J Psychiatry Brain Sci. https:\/\/doi.org\/10.20900\/jpbs.20200009","DOI":"10.20900\/jpbs.20200009"},{"key":"9082_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/pon.1431","volume":"18","author":"BJA Laird","year":"2009","unstructured":"Laird BJA, Boyd AC, Colvin LA, Fallon MT (2009) Are cancer pain and depression interdependent? A systematic review. Psychooncology 18:459\u2013464. https:\/\/doi.org\/10.1002\/pon.1431","journal-title":"Psychooncology"},{"key":"9082_CR30","doi-asserted-by":"crossref","unstructured":"Donovan KA, Thompson LMA, Jacobsen PB (2013) Pain, Depression, and Anxiety in Cancer. In: Moore RJ (ed) Handbook of Pain and Palliative Care. Springer New York, New York, NY, pp 615\u2013637","DOI":"10.1007\/978-1-4419-1651-8_33"},{"key":"9082_CR31","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1200\/JCO.2013.52.5170","volume":"32","author":"E Del Fabbro","year":"2014","unstructured":"Del Fabbro E (2014) Assessment and Management of Chemical Coping in Patients With Cancer. J Clin Oncol 32:1734\u20131738. https:\/\/doi.org\/10.1200\/JCO.2013.52.5170","journal-title":"J Clin Oncol"},{"key":"9082_CR32","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11606-013-2648-1","volume":"29","author":"JF Scherrer","year":"2014","unstructured":"Scherrer JF, Svrakic DM, Freedland KE et al (2014) Prescription Opioid Analgesics Increase the Risk of Depression. J Gen Intern Med 29:491\u2013499. https:\/\/doi.org\/10.1007\/s11606-013-2648-1","journal-title":"J Gen Intern Med"},{"key":"9082_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1370\/afm.1885","volume":"14","author":"JF Scherrer","year":"2016","unstructured":"Scherrer JF, Salas J, Copeland LA et al (2016) Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Ann Fam Med 14:54\u201362. https:\/\/doi.org\/10.1370\/afm.1885","journal-title":"Ann Fam Med"},{"key":"9082_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamapsychiatry.2020.3554","volume":"78","author":"DB Rosoff","year":"2021","unstructured":"Rosoff DB, Smith GD, Lohoff FW (2021) Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable mendelian randomization analysis. JAMA Psychiat 78:151. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.3554","journal-title":"JAMA Psychiat"},{"key":"9082_CR35","doi-asserted-by":"publisher","first-page":"108367","DOI":"10.1016\/j.jsat.2021.108367","volume":"127","author":"N Kumar","year":"2021","unstructured":"Kumar N, Oles W, Howell BA et al (2021) The role of social network support in treatment outcomes for medication for opioid use disorder: A systematic review. J Subst Abuse Treat 127:108367. https:\/\/doi.org\/10.1016\/j.jsat.2021.108367","journal-title":"J Subst Abuse Treat"},{"key":"9082_CR36","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00127-021-02199-2","volume":"57","author":"J Van Draanen","year":"2022","unstructured":"Van Draanen J, Tsang C, Mitra S et al (2022) Mental disorder and opioid overdose: a systematic review. Soc Psychiatry Psychiatr Epidemiol 57:647\u2013671. https:\/\/doi.org\/10.1007\/s00127-021-02199-2","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"9082_CR37","doi-asserted-by":"publisher","first-page":"E173","DOI":"10.1503\/cmaj.200016","volume":"192","author":"J Downar","year":"2020","unstructured":"Downar J, Fowler RA, Halko R et al (2020) Early experience with medical assistance in dying in Ontario, Canada: a cohort study. Can Med Assoc J 192:E173\u2013E181. https:\/\/doi.org\/10.1503\/cmaj.200016","journal-title":"Can Med Assoc J"},{"key":"9082_CR38","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1002\/pon.6196","volume":"32","author":"M Henry","year":"2023","unstructured":"Henry M, Alias A, Bisson-Gervais V et al (2023) Medical assistance in dying in Canada: A scoping review on the concept of suffering. Psychooncology 32:1339\u20131347. https:\/\/doi.org\/10.1002\/pon.6196","journal-title":"Psychooncology"},{"key":"9082_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.genhosppsych.2019.07.003","volume":"60","author":"Y Kawashima","year":"2019","unstructured":"Kawashima Y, Yonemoto N, Inagaki M et al (2019) Interventions to prevent suicidal behavior and ideation for patients with cancer: A systematic review. Gen Hosp Psychiatry 60:98\u2013110. https:\/\/doi.org\/10.1016\/j.genhosppsych.2019.07.003","journal-title":"Gen Hosp Psychiatry"},{"key":"9082_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/11536540-000000000-00000","volume":"27","author":"H Smith","year":"2010","unstructured":"Smith H, Bruckenthal P (2010) Implications of opioid analgesia for medically complicated patients. Drugs Aging 27:417\u2013433. https:\/\/doi.org\/10.2165\/11536540-000000000-00000","journal-title":"Drugs Aging"},{"key":"9082_CR41","doi-asserted-by":"publisher","first-page":"e625","DOI":"10.3399\/bjgp12X654597","volume":"62","author":"B Thoonsen","year":"2012","unstructured":"Thoonsen B, Engels Y, Van Rijswijk E et al (2012) Early identification of palliative care patients in general practice: development of RADboud indicators for PAlliative Care Needs (RADPAC). Br J Gen Pract 62:e625\u2013e631. https:\/\/doi.org\/10.3399\/bjgp12X654597","journal-title":"Br J Gen Pract"},{"key":"9082_CR42","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jpainsymman.2007.02.006","volume":"33","author":"L De Lima","year":"2007","unstructured":"De Lima L, Krakauer EL, Lorenz K et al (2007) Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care. J Pain Symptom Manag 33:521\u2013526. https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.02.006","journal-title":"J Pain Symptom Manag"},{"key":"9082_CR43","doi-asserted-by":"publisher","first-page":"5835","DOI":"10.3390\/curroncol30060437","volume":"30","author":"H Harsanyi","year":"2023","unstructured":"Harsanyi H, Cuthbert C, Schulte F (2023) The stigma surrounding opioid use as a barrier to cancer-pain management: an overview of experiences with fear, shame, and poorly controlled pain in the context of advanced cancer. Curr Oncol 30:5835\u20135848. https:\/\/doi.org\/10.3390\/curroncol30060437","journal-title":"Curr Oncol"},{"key":"9082_CR44","doi-asserted-by":"publisher","first-page":"e0257794","DOI":"10.1371\/journal.pone.0257794","volume":"16","author":"K Fiscella","year":"2021","unstructured":"Fiscella K, Epstein RM, Griggs JJ et al (2021) Is physician implicit bias associated with differences in care by patient race for metastatic cancer-related pain? PLoS ONE 16:e0257794. https:\/\/doi.org\/10.1371\/journal.pone.0257794","journal-title":"PLoS ONE"},{"key":"9082_CR45","doi-asserted-by":"publisher","first-page":"e082033","DOI":"10.1136\/bmjopen-2023-082033","volume":"14","author":"S Fereydooni","year":"2024","unstructured":"Fereydooni S, Lorenz K, Azarfar A et al (2024) Identifying provider, patient and practice factors that shape long-term opioid prescribing for cancer pain: a qualitative study of American and Australian providers. BMJ Open 14:e082033. https:\/\/doi.org\/10.1136\/bmjopen-2023-082033","journal-title":"BMJ Open"}],"updated-by":[{"DOI":"10.1007\/s00520-025-09161-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000}}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-09082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-09082-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-09082-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T02:29:49Z","timestamp":1738376989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-09082-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["9082"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-09082-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"17 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00520-025-09161-x","URL":"https:\/\/doi.org\/10.1007\/s00520-025-09161-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Health Research Ethics Board of Alberta\u00a0(HREBA.CC-23\u20130270) and was completed in accordance with ethical standards outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}